Literature DB >> 646347

Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

J N Galgiant, D A Stevens.   

Abstract

Susceptibility testing with the broth-dilution visual end-point method is inoculum dependent with miconazole and 5-fluorocystosine, but not with amphotericin B. Turbidimetric measurements of yeast growth in the presence of antifungal drugs were therefore performed. With miconazole and 5-fluorocytosine, over the range of concentrations studied, growth occurred until a plateau phase was reached. With drug present prior to log phase growth, a delayed onset of effect was noted which was proportional to the generation time of the organism. With amphotericin B, in contrast, there was sharp transition with increasing drug concentration from no inhibition to complete arrest of growth, and no relation of onset of effect to generation time. These findings provide a possible explanation of inoculum dependence; i.e., at higher inocula, partially inhibited but growing yeasts become visible at higher drug concentrations. Supporting evidence derives from observations with different starting inocula, varying time of reading end points, and other methods of studying growth inhibition. The delay in miconazole and 5-fluorocytosine effect described suggests that rapid methods of susceptibility testing should be utilized with cultures already in log phase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646347      PMCID: PMC352222          DOI: 10.1128/AAC.13.2.249

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Amphotericin B. Old drug, new therapy.?2110.

Authors:  G Medoff; G S Kobayashi
Journal:  JAMA       Date:  1975-05-12       Impact factor: 56.272

2.  Obfuscation of the activity of antifungal antimicrobics by culture media.

Authors:  P D Hoeprich; P D Finn
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

3.  Characterization of the binding of amphotericin B to Saccharomyces cerevisiae and relationship to the antifungal effects.

Authors:  J Kotler-Brajtburg; G Medoff; D Schlessinger; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

4.  The action of miconazole of the growth of Candida albicans.

Authors:  H Van Den Bossche; G Willemsens; J M Van Cutsem
Journal:  Sabouraudia       Date:  1975-03

5.  Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents.

Authors:  P Benitez; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

6.  Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans.

Authors:  K H Sreedhara Swamy; M Sirsi; G R Ramananda Rao
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

7.  Rubidium release: a rapid and sensitive assay for amphotericin B.

Authors:  R E Drazin; R I Lehrer
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

8.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

9.  Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

10.  In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.

Authors:  S Shadomy; C B Kirchoff; A E Ingroff
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  34 in total

1.  Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods.

Authors:  C Llop; I Pujol; C Aguilar; J Sala; D Riba; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.

Authors:  A Espinel-Ingroff; T M Kerkering
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

3.  The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination.

Authors:  Kenneth P Smith; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.

Authors:  M Schäfer-Korting; H C Korting; F Amann; R Peuser; A Lukacs
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.

Authors:  T V Krishnarao; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

6.  Variability of agar dilution-replicator method of yeast susceptibility testing.

Authors:  C Brass; J Z Shainhouse; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

7.  Broth dilution testing of Candida albicans susceptibility to ketoconazole.

Authors:  C E Hughes; R L Bennett; W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 8.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

10.  Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination.

Authors:  M M Albert; J R Graybill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.